Pharmaceutical Gelatin Market - By Product (Type A, Type B), Source (Porcine, Bovine, Fish, Poultry), Function (Stabilizers, Thickeners, Gelling Agents, Film Forming), Application (Capsules, Tablets, Absorbable hemostats), Global Forecast 2023-2032
Published Date: August - 2024 | Publisher: MIR | No of Pages: 240 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationPharmaceutical Gelatin Market - By Product (Type A, Type B), Source (Porcine, Bovine, Fish, Poultry), Function (Stabilizers, Thickeners, Gelling Agents, Film Forming), Application (Capsules, Tablets, Absorbable hemostats), Global Forecast 2023-2032
Pharmaceutical Gelatin Market size
Pharmaceutical Gelatin Market size was valued at around USD 1.1 billion in 2022 and is estimated to reach USD 1.9 billion by 2032. Increasing burden of chronic disease is expected to increase the demand for pharmaceutical-grade gelatin.
Also, expanding developments of gelatin nanoparticles in medications and vaccines are driving the market expansion. Growing use of gelatin in cosmetics, intrinsic activities, biomedical applications such as wound treatment & healing, and bone substitutes are observed in several studies with new developments in the market. For instance, according to the National Institute of Health (NIH) study, it was found that bovine hydroxyapatite-gelatin-hydroxypropyl methylcellulose with alendronate was utilized as injectable bone substitute (IBS) for the treatment of bone with osteoporosis in animal model.
| Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| Pharmaceutical Gelatin Market Size in 2022 | USD 1.1 billion |
| Forecast Period | 2023 to 2028 |
| Forecast Period 2023 to 2028 CAGR | 5.6% |
| 2028 Value Projection | USD 1.9 billion |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 150 |
| Tables, Charts & Figures | 308 |
| Segments covered | Type, Source, Function, Application and Region |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
Pharmaceutical gelatin is generated from animal skin, white connective tissues, and bones. They comprises high molecular weight, thermo-reversible, biocompatible and are water soluble in nature. It is a common excipient used in the manufacture of hard capsules and soft gels. Furthermore, it is utilized as a binder in tablets, blood plasma substitutes among other applications.
COVID-19 Impact
The COVID-19 pandemic sent shockwaves through the world, putting a huge strain on our healthcare systems. Hospitals filled up as the virus spread, and it didn't just stop there. Businesses of all kinds, including healthcare, took a big hit during 2020 and early 2021. Many medical checkups and procedures had to be put on hold as a result. To make matters worse, the pandemic caused a shortage of gelatin, a key ingredient in many medicines. Drug companies rely on animal products, especially for making capsules. But when lockdowns and travel restrictions were put in place, it messed up the whole process of getting animals to slaughterhouses and moving their products around.
Furthermore, restrictions on employee movement and a brief halt on manufacturing units impacted gelatin productivity. As a result, the manufacturing valued chain was impeded throughout the pandemic period. However, with the relaxation of regulations and a surge in demand for gelatin in the pharmaceutical industry, the global market expanded in late 2020.
Pharmaceutical Gelatin Market Trends
The push by big players to create cutting-edge gelatin capsule shells using new tech is opening up tons of chances for the market to grow. For instance, etectRx, Inc., a healthcare startup, is looking into how well prescription opioid users with HIV stick to their antiretroviral meds. In a study called "MyTPill," the ID-Cap System will be used. It's a hard gelatin capsule with a wireless sensor you can swallow and a device you can wear on your body to keep track of how well patients follow their treatment plans. These kinds of moves by companies are expected to increase the use of gelatin in making hard gelatin capsules (like ID-Cap), which will boost the market's revenue.
Pharmaceutical Gelatin Market Analysis
Based on type, the pharmaceutical gelatin market is segmented as type A and type B. The Type B category dominated the market with a business share of 65.4% in the year 2022. The dominance is due to a variety of factors including cost-effective production due to the availability of raw materials and its use in a variety of applications across the pharmaceutical industry. Also, type B gelatin provide increased gel storage stability than low-bloom gelatin that enables industry players to opt for such product type, thereby augmenting the segment landscape.
Based on source, the pharmaceutical gelatin market is segmented into porcine, bovine, fish, and poultry. Porcine source dominated the market with revenue of 520.5 million in 2022. The quick manufacturing cycle, cost-effective production and utilization of porcine based products in pharmaceutical industry are few significant aspects for driving the segment share. For instance, according to the National Health Service (NHS), the use of porcine-based products as a stabiliser in various vaccines and capsules to maintain efficacy and safety, particularly during and after storage.
Based on function, Based on function, the pharmaceutical gelatin market is segmented into stabilizers, thickeners, gelling agents, film forming, adhesion and other functions. The stabilizers segment is expected to show considerable growth of 7.4% during the analysis period. The rising use of gelatin as a vaccine stabilizer is projected to fuel segment outlook. Few vaccines contain a stabilizer made from well processed gelatin with minimal endotoxin levels that help in lowering the risk of side effects and assuring patient safety. It also aids in the stability of lyophilized (freeze-dried) products.
Based on application, the pharmaceutical gelatin market is segmented into capsules, tablets, absorbable haemostats & other applications. Further, the capsules segment are sub-divided into hard and soft capsules. The capsules segment dominated the market in 2022 and is estimated to reach 970.6 million by 2032. The gelatin softgel capsule offer several advantages such as ease of swallowing, longer shelf life and taste masking will propel the segment development. Moreover, high preference of pharmaceutical manufacturer for gelatin based empty capsules for different formulations due to non-reactive nature and ease of use is anticipated to supplement the capsule market share.
Hey there, you know about the pharmaceutical gelatin market in North America? It's pretty big, making up about 41.2% of the world market in 2022. Why is it so big in North America? Well, it's got big players in the game and a super developed healthcare system. Plus, a lot of companies in North America are making gelatin capsules, which is a big deal for the market. For example, there's CapsCanada, which is helping companies make those liquid-filled hard capsules. They're doing everything from research to production, so it's making it easier for companies to use pharmaceutical gelatin in their products. So, with all these factors working together, the pharmaceutical gelatin market in North America is set to keep growing and growing.
Pharmaceutical Gelatin market Share
Some of the major market players operating in the pharmaceutical gelatin industry are
- NITTA GELATIN, INC
- GELITA AG
- Tessenderlo Group (PB Leiner)
- Weishardt
- Trobas Gelatine B.V
- Lonza
- India Gelatine & Chemicals Ltd
- Gelnex
- Juncà Gelatines SL
- ITALGEL S.p.A
These players focus on strategic partnerships, new product launch & commercialization for market expansion. Furthermore, these players are heavily investing in research that allows them to introduce innovative products and garner maximum revenue in the market.
Pharmaceutical Gelatin market News
- In May 2022, Capsugel enhanced its titanium dioxide-free capsule line by offering white firm gelatin capsules without titanium dioxide (TiO2-free). The new titanium dioxide-free capsule is based on crystalline salts and provides similar masking and whitening as titanium dioxide capsules. The product provides great light shielding and opacity.
In January 2022, Terasaki Institute for Biomedical Innovation (TIBI) collaborated with Rousselot, a Darling Ingredients company. The collaboration aimed to advance gelatin-based therapies with Rousselot's X-Pure modified gelatin range. This strategy is expected to enhance their long-term business relations.
The pharmaceutical gelatin market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments
Click here to Buy Section of this Report
By Type, 2018 - 2032 (USD Million)
- Type A
- Type B
By Source, 2018 - 2032 (USD Million)
- Porcine
- Bovine
- Fish
- Poultry
By Function, 2018 - 2032 (USD Million)
- Stabilizers
- Thickeners
- Gelling agents
- Film forming
- Adhesion
- Other functions
By Application, 2018 – 2032 (USD Million)
- Capsules
- Hard capsules
- Soft capsules
- Tablets
- Absorbable hemostats
- Other applications
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- Rest of Middle East & Africa
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy